The global inhaled nitric oxide delivery systems market value was US$ 247.5 million in 2020. The global inhaled nitric oxide delivery systems market value is forecast to reach US$ 496 million by 2030, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2021-2030.
A delivery system for inhaled nitric oxide aids in relaxing smooth muscle, resulting in widening (dilating) blood vessels, specifically in the lungs, that assimilate through a diverse range of conditions. Inhalation of nitric oxide sometimes serves to treat chronic respiratory diseases and treat infants with severe breathing problems associated with narrow blood vessels in the lungs.
Factors Influencing Market Growth
The increase in R&D activity designed to improve the patient experience in the healthcare sector is a primary factor boosting the global market for inhaled nitric oxide delivery systems.
Increasing geriatric populations with progressive lung conditions may increase demand for global inhaled nitric oxide delivery systems market.
The increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease and asthma may also contribute to the rapid growth of the global inhaled nitric oxide delivery system market.
A favorable government initiative and rising concerns about health in developed economies will also boost the market for inhaled nitric oxide delivery systems.
There are strict application regulations across various geographic regions for inhaled nitric oxide delivery systems. This factor may slow down the global market's growth.
Impact Analysis of COVID-19
The COVID-19 pandemic had a positive impact on the global inhaled nitric oxide delivery systems market. Due to nitric oxide's antiviral properties and increased oxygenation, researchers tested it as an alternative treatment for COVID-19. Additionally, it helps protect healthcare workers on the front line from getting ill from the pandemic. In addition, nitric oxide inhaled in COVID-19 was evaluated in several randomized clinical trials to treat pulmonary hypertension, Acute respiratory distress syndrome (ARDS), and other respiratory diseases. Additionally, inhaled nitric oxide is currently undergoing multiple clinical trials as a treatment for COVID-19, with promising results in clinical trials.
Regional Insights
During the forecast period, North America is forecast to register the fastest CAGR. The growth is mainly due to the rising rates of neonatal mortality caused by the epidemic of HRF. A rise in INO therapy adoption, favorable government policies, and the presence of advanced medical infrastructure all contribute to regional growth.

During the forecast period, Asia Pacific will have the largest revenue share due to the growing pediatric population, an increase in respiratory failure patients, and the presence of local manufacturers of nitric oxide disposables & systems.
Leading Competitors
The leading prominent companies profiled in the global inhaled nitric oxide delivery system market are:
Air Liquide Healthcare
Bellerophon Therapeutics
Beyond Air
Circassia Pharmaceuticals
Getinge
LINDE
Mallinckrodt Pharmaceuticals
NU MED
SLE
Vero Biotech
Other Prominent Players
Scope of the Report
The global inhaled nitric oxide delivery system market segmentation focuses on Type, Application, Product, End-user, and Region.
Segmentation based on Type
Pediatrics
Adult
Segmentation based on Application
Neonatal Respiratory Treatment
Chronic obstructive pulmonary disease (COPD)
Malaria Treatment
Tuberculosis Treatment
Acute respiratory distress syndrome (ARDS)
Chronic Wound Healing
Others
Segmentation based on End-user
Hospitals
Ambulatory Centers
Clinics
Segmentation based on Region
North America
o The U.S.
o Canada
o Mexico
Europe
? Western Europe
o The UK
o Germany
o France
o Italy
o Spain
o Rest of Western Europe
? Eastern Europe
o Poland
o Russia
o Rest of Eastern Europe
Asia Pacific
o China
o India
o Japan
o Australia & New Zealand
o ASEAN
o Rest of Asia Pacific
Middle East & Africa (MEA)
o UAE
o Saudi Arabia
o South Africa
o Rest of MEA
South America
o Brazil
o Argentina
o Rest of South America

Meta Title: Inhaled Nitric Oxide Delivery Systems Market Share, Size, Trends and Forecast Till 2030
Meta Description: The global inhaled nitric oxide delivery systems market value is forecast to reach US$ 496 million by 2030, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2021-2030.
Meta Keywords: Inhaled Nitric Oxide Delivery Systems Market, Inhaled Nitric Oxide Delivery Systems Market Share, Inhaled Nitric Oxide Delivery Systems Market Size, Inhaled Nitric Oxide Delivery Systems Market Insights, Inhaled Nitric Oxide Delivery Systems Market Trends, Inhaled Nitric Oxide Delivery Systems Market Forecast